These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11833359)

  • 1. Crystal structure of calpain and insights into Ca(2+)-dependent activation.
    Jia Z; Hosfield CM; Davies PL; Elce JS
    Methods Mol Biol; 2002; 172():51-67. PubMed ID: 11833359
    [No Abstract]   [Full Text] [Related]  

  • 2. Crystallization and structural details of Ca(2+)-induced conformational changes in the EF-hand domain VI of calpain.
    Cygler M; Grochulski P; Blanchard H
    Methods Mol Biol; 2002; 172():243-60. PubMed ID: 11833352
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation.
    Hosfield CM; Elce JS; Davies PL; Jia Z
    EMBO J; 1999 Dec; 18(24):6880-9. PubMed ID: 10601010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second binding site revealed by C-terminal truncation of calpain small subunit, a penta-EF-hand protein.
    Leinala EK; Arthur JS; Grochulski P; Davies PL; Elce JS; Jia Z
    Proteins; 2003 Nov; 53(3):649-55. PubMed ID: 14579356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
    Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of individual EF-hands in the activation of m-calpain by calcium.
    Dutt P; Arthur JS; Grochulski P; Cygler M; Elce JS
    Biochem J; 2000 May; 348 Pt 1(Pt 1):37-43. PubMed ID: 10794711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence measurements of Ca2+ binding to domain VI of calpain.
    Arthur JS; Elce JS
    Methods Mol Biol; 2000; 144():121-7. PubMed ID: 10818756
    [No Abstract]   [Full Text] [Related]  

  • 9. How calpain is activated by calcium.
    Khorchid A; Ikura M
    Nat Struct Biol; 2002 Apr; 9(4):239-41. PubMed ID: 11914728
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain silencing by a reversible intrinsic mechanism.
    Moldoveanu T; Hosfield CM; Lim D; Jia Z; Davies PL
    Nat Struct Biol; 2003 May; 10(5):371-8. PubMed ID: 12665854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural biology: Enzyme knocked for a loop.
    Mellgren RL
    Nature; 2008 Nov; 456(7220):337-8. PubMed ID: 19020611
    [No Abstract]   [Full Text] [Related]  

  • 13. Flexibility analysis and structure comparison of two crystal forms of calcium-free human m-calpain.
    Reverter D; Braun M; Fernandez-Catalan C; Strobl S; Sorimachi H; Bode W
    Biol Chem; 2002 Sep; 383(9):1415-22. PubMed ID: 12437134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain.
    Dutt P; Spriggs CN; Davies PL; Jia Z; Elce JS
    Biochem J; 2002 Oct; 367(Pt 1):263-9. PubMed ID: 12014988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site.
    Moldoveanu T; Campbell RL; Cuerrier D; Davies PL
    J Mol Biol; 2004 Nov; 343(5):1313-26. PubMed ID: 15491615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu-calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation.
    Fernández-Montalván A; Assfalg-Machleidt I; Pfeiler D; Fritz H; Jochum M; Machleidt W
    Biol Chem; 2006 May; 387(5):617-27. PubMed ID: 16740134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in the design and synthesis of calpain inhibitors.
    Neffe AT; Abell AD
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ca(2+) switch aligns the active site of calpain.
    Moldoveanu T; Hosfield CM; Lim D; Elce JS; Jia Z; Davies PL
    Cell; 2002 Mar; 108(5):649-60. PubMed ID: 11893336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of a calpain Ca(2+)-binding domain reveals a novel EF-hand and Ca(2+)-induced conformational changes.
    Blanchard H; Grochulski P; Li Y; Arthur JS; Davies PL; Elce JS; Cygler M
    Nat Struct Biol; 1997 Jul; 4(7):532-8. PubMed ID: 9228945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium binding to the transmembrane domain of the sarcoplasmic reticulum Ca2+-ATPase: insights from molecular modeling.
    Costa V; Carloni P
    Proteins; 2003 Jan; 50(1):104-13. PubMed ID: 12471603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.